is NOW APPROVED in the U.S. Learn more in our press release.

Media
Investors
Contact Us

Medicines
Stories
Careers

Our Science

Pipeline Explore our pipeline of investigational RAS(ON) inhibitors.
Tri-Complex Platform and RAS(ON) Biology Explore RAS(ON) biology and the platform driving targeted therapy discovery and development.
Research, Grants & Support Learn about funding, research collaboration, and community support at RevMed.
Publications Access scientific publications, congress presentations, and RAS(ON) research.

Our Company

About RevMed Learn about our mission, values, and the team advancing therapies for RAS-addicted cancers.
Responsibility Learn about our approach to pricing and patient access, and corporate responsibility.

Medicines
Stories
- About RevMed Learn about our mission, values, and the team advancing therapies for RAS-addicted cancers.
- Responsibility Learn about our approach to pricing and patient access, and corporate responsibility.
Careers
Media
Investors
Contact Us